GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $70,590 | -69.4% | 36,200 | -56.3% | 0.00% | -100.0% |
| Q1 2023 | $230,462 | -67.5% | 82,900 | -59.7% | 0.00% | -50.0% |
| Q4 2022 | $709,682 | +21.1% | 205,705 | -9.8% | 0.00% | 0.0% |
| Q3 2022 | $586,000 | +41.5% | 227,944 | +33.2% | 0.00% | +100.0% |
| Q2 2022 | $414,000 | +216.0% | 171,104 | +438.9% | 0.00% | – |
| Q1 2022 | $131,000 | -96.4% | 31,753 | -92.0% | 0.00% | -100.0% |
| Q2 2021 | $3,621,000 | +58.3% | 396,659 | +63.5% | 0.01% | +33.3% |
| Q1 2021 | $2,288,000 | +208.4% | 242,599 | +117.1% | 0.01% | +50.0% |
| Q2 2020 | $742,000 | +466.4% | 111,760 | +395.7% | 0.00% | +300.0% |
| Q1 2020 | $131,000 | -7.1% | 22,548 | +43.2% | 0.00% | – |
| Q4 2019 | $141,000 | -30.5% | 15,750 | -13.5% | 0.00% | -100.0% |
| Q2 2019 | $203,000 | – | 18,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |